PT3644970T - New oral formulations of belinostat - Google Patents

New oral formulations of belinostat

Info

Publication number
PT3644970T
PT3644970T PT187372255T PT18737225T PT3644970T PT 3644970 T PT3644970 T PT 3644970T PT 187372255 T PT187372255 T PT 187372255T PT 18737225 T PT18737225 T PT 18737225T PT 3644970 T PT3644970 T PT 3644970T
Authority
PT
Portugal
Prior art keywords
belinostat
oral formulations
new oral
new
formulations
Prior art date
Application number
PT187372255T
Other languages
Portuguese (pt)
Original Assignee
Acrotech Biopharma Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acrotech Biopharma Llc filed Critical Acrotech Biopharma Llc
Publication of PT3644970T publication Critical patent/PT3644970T/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT187372255T 2017-07-03 2018-06-29 New oral formulations of belinostat PT3644970T (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17305853 2017-07-03

Publications (1)

Publication Number Publication Date
PT3644970T true PT3644970T (en) 2022-04-05

Family

ID=59313174

Family Applications (1)

Application Number Title Priority Date Filing Date
PT187372255T PT3644970T (en) 2017-07-03 2018-06-29 New oral formulations of belinostat

Country Status (3)

Country Link
EA (1) EA039150B1 (en)
PT (1) PT3644970T (en)
WO (1) WO2019002614A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4292591A1 (en) 2022-06-14 2023-12-20 Universitätsmedizin Greifswald Compounds for use in the treatment of kidney diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4975941B2 (en) 2000-09-29 2012-07-11 トポターゲット ユーケー リミテッド (E) -N-hydroxy-3- (3-sulfamoyl-phenyl) acrylamide compound and therapeutic use thereof
RU2004123621A (en) * 2002-02-01 2005-04-10 Пфайзер Продактс Инк. (Us) MEDICINAL FORMS WITH IMMEDIATE RELEASE CONTAINING SOLID DISPERSIONS OF MEDICINES
AU2012213940B2 (en) * 2005-05-13 2015-03-26 Topotarget Uk Limited Pharmaceutical formulations of HDAC inhibitors
WO2011064663A1 (en) * 2009-11-25 2011-06-03 Festuccia, Claudio Combination treatment employing belinostat and bicalutamide
GB201217439D0 (en) * 2012-09-28 2012-11-14 Topotarget As Combination therapy
US9114170B2 (en) * 2012-11-08 2015-08-25 Isp Investments Inc. Highly loaded amorphous efavirenz composition and process for preparing the same

Also Published As

Publication number Publication date
EA201992844A1 (en) 2020-05-06
WO2019002614A1 (en) 2019-01-03
EA039150B1 (en) 2021-12-10

Similar Documents

Publication Publication Date Title
ZA201903452B (en) Oral care compositions
IL257658B (en) Oral care compositions
GB201611547D0 (en) Oral cannabinoid formulations
ZA201903460B (en) Oral care compositions
IL257659B (en) Oral care compositions
IL259044B (en) Oral care compositions
ZA201807771B (en) Oral care compositions
ZA201903431B (en) Oral care compositions
ZA201706785B (en) Oral care compositions
ZA201903379B (en) Oral care compositions
ZA201803909B (en) Oral care compositions
IL272857A (en) Formulations of copanlisib
ZA201903451B (en) Oral care compositions
ZA201903430B (en) Oral care compositions
ZA201901982B (en) Oral care compositions
IL283593A (en) Oral formulations of branaplam
ZA202001909B (en) Oral care compositions
IL258305A (en) Oral care compositions
IL271658B1 (en) New oral formulations of belinostat
ZA201800096B (en) Oral care compositions
PT3644970T (en) New oral formulations of belinostat
IL268632A (en) Solid oral formulations of amphotericin b
ZA201901981B (en) Oral care compositions
PT3678644T (en) Formulations of copanlisib
ZA201801992B (en) Oral care compositions